{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "OTLY",
  "name": "Oatly Group AB",
  "url": "https://frontierpicks.com/dossiers/OTLY/",
  "json_url": "https://frontierpicks.com/dossiers/OTLY.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "The 2026-07-22 guidance doubling (FY constant-currency growth 8–10% from 3–5%) is now a month old with no follow-on news; RSI(14) reset from 71.0 on 2026-08-07 to 43.7 on 2026-08-21 while price held, leaving a $13.03–$13.15 shelf. Nothing company-scheduled before the ~2026-10-28 Q3 print, against $517.8M borrowings, $44.6M cash and a $462.7M market cap.",
  "invalidation_trigger": "A weekly close below $13.00 removes the August 2026 shelf (closes of $13.035 on 2026-08-11 and $13.150 on 2026-08-12), the only floor the post-guidance advance built; secondarily, a Q3 2026 print (~2026-10-28, est.) walking FY constant-currency growth back toward 3–5% or narrowing adjusted EBITDA below $25M.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "consumer-discretionary-rotation",
    "managed-care-health-services"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Foreign private issuer: reports on Form 6-K and 20-F, not 10-Q/10-K.",
    "Reports in USD while the largest growth region is European, so reported and constant-currency growth diverge every quarter.",
    "9.25% Convertible Senior PIK Notes due 2028-09-14 accrete interest rather than pay cash, so principal compounds absent repurchase.",
    "Capital stack is multi-currency: SEK 1,700M Nordic bonds and a SEK 750M super senior RCF alongside the USD convertibles.",
    "Sell-side coverage is thin and aggregator target sets disagree: a one-analyst $14.00 alongside a six-analyst average of $17.25 in August 2026.",
    "31.91M shares outstanding gives a small float; single-print moves and index/screen flows can dominate short-run price action."
  ],
  "body_markdown": "## Current Thesis\n\nThe leg on offer is unchanged in substance and older in time: an operating inflection printed on 2026-07-22 — Q2 net revenue $240.1M (+15.2% reported, +12.7% constant currency) against a $218.961M consensus, adjusted EBITDA crossing positive at +$0.4M, and FY2026 constant-currency growth guidance doubled to 8–10% from 3–5% — sitting on top of $517.8M of total borrowings against $44.6M of cash at 2026-06-30.\n\nWhat has changed since the last write-up is the market's condition, not the fundamentals. On the 2026-08-07 close of $13.72, RSI(14) read 71.0. On the 2026-08-21 close of $14.50, RSI(14) reads 43.7. In between, the stock closed at $13.035 on 2026-08-11 and $13.150 on 2026-08-12 (per contemporaneous quote data), then recovered. The overbought reading was worked off through time and a shallow dip rather than a full retracement — an inference from the price path, not a company event. No press release, no SEC filing and no dated sell-side action surfaced between 2026-07-24 and 2026-08-21; an EDGAR search returned no August 2026 Form 6-K.\n\n**The narrative is maturing.** The story is fully disclosed and still working — the shares are up 42.9% over three months — but the flow that carried it has moderated: last company headline 2026-07-24, no new information for roughly four weeks, and no scheduled company event before the estimated late-October Q3 print. It is no longer accelerating because the headline stream stopped; it is not saturated because the price never reached the $18.54 52-week high (-21.8% from it at $14.50) and sell-side participation stayed thin (JPMorgan and Morgan Stanley at hold in late July 2026).\n\n## Bull Case\n\n- FY2026 constant-currency revenue growth guidance raised to **8–10% from 3–5%** on 2026-07-22 — the growth assumption doubled inside one quarter.\n- Q2 2026 revenue $240.095M vs $218.961M consensus; EPS -$0.99 vs -$1.06 consensus (Benzinga, 2026-07-22). Six-month revenue $468.4M.\n- Adjusted EBITDA turned positive at **+$0.4M** (from -$3.6M in Q2 2025); gross margin **33.9%, +140bps**; net loss narrowed to $31.3M from $55.9M.\n- Regional breadth in the quarter: Europe & International +21.0% reported (+18.0% cc); Greater China +11.6% (+5.6% cc); North America +5.9% with a second consecutive quarter of positive volume growth.\n- Low capital intensity relative to the growth rate: H1 2026 capex $10.7M.\n- Barclays kept Overweight and raised its target to $14 on 2026-07-23, two days after cutting it to $12. Aggregator target sets disagree materially: WallStreetZen shows a one-analyst 12-month target of $14.00, while a six-analyst set tracked in August 2026 averages $17.25 with a $24.00 high and a $12.00 low.\n- The August drawdown to the $13.03–$13.15 area held and the 2026-08-21 close of $14.50 is above the 2026-08-07 close of $13.72 — the guidance-raise gap has not been filled back.\n\n## Bear Case\n\n- **Debt exceeds the equity.** $517.8M of total borrowings against $44.6M of cash at 2026-06-30, versus a market capitalisation of $462.73M on 31.91M shares outstanding at the 2026-08-21 close (stockanalysis.com, checked 2026-08-22). The 9.25% Convertible Senior PIK Notes due **2028-09-14** accrete rather than pay cash, so principal compounds absent repurchase.\n- The dollar guide moved from $866.725M–$883.555M to $908.799M–$925.629M against a $917.899M consensus (Benzinga, 2026-07-22) — the midpoint met the Street rather than clearing it.\n- Reported growth of 15.2% versus 12.7% constant currency is roughly 250bps of currency help in a company that reports in USD while its fastest-growing region is European.\n- Management pointed to the **low end** of the $25–35M FY adjusted-EBITDA range on the 2026-07-22 call.\n- Still loss-making at -$31.3M in the quarter, with one quarter of positive adjusted EBITDA as the entire track record of the inflection.\n- Four weeks without a company datapoint, and roughly nine weeks until the next one. A re-rating that depends on a single guide has nothing scheduled to refresh it.\n\n## Setup & Price Structure\n\n- Reference close 2026-08-21: **$14.50**. 52-week high $18.54, so -21.8% below it. Three-month price change +42.9%. RSI(14) 43.7.\n- The only structure the post-guidance advance has built is the August consolidation shelf marked by the $13.035 close on 2026-08-11 and the $13.150 close on 2026-08-12. Below that, the next reference is the pre-2026-07-22 range that the print gapped out of.\n- **Crowding/positioning observables, stated as observables.** RSI(14) fell from 71.0 (2026-08-07) to 43.7 (2026-08-21) with price higher — the momentum-screen hook that produced the 2026-07-24 Benzinga RSI piece has cooled. There is no new 52-week high to attract breakout participation. No earnings date falls inside 30 days. No August 2026 company filing surfaced on EDGAR, so no issuance-into-strength or insider transaction is on the record for the period; that is an absence of data, not evidence of none. Float is small: 31.91M shares outstanding.\n- Analyst dispersion is wide relative to the price — a $12.00 low and a $24.00 high in the six-analyst aggregate — which is what thin coverage of a levered turnaround looks like.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-22 → 2026-09-21:** no company-scheduled event identified. No earnings date, no capital-markets day, no regulatory deadline is on the calendar inside the window.\n- **~2026-10-28 (est.):** Q3 2026 results. Date unconfirmed; Q3 2025 was reported 2025-10-29 and Q3 2024 on 2024-11-07. This is the first hard test of the 8–10% constant-currency guide and of whether adjusted EBITDA tracks the $25M low end or the $35M high end, plus the next disclosure of cash against the $517.8M borrowing balance.\n- **2028-09-14:** maturity of the 9.25% Convertible Senior PIK Notes — a standing structural date, not a near-term event, but the reason any interim financing announcement would be material.\n\n## What Would Change Our Mind\n\nThe structure that matters is the August shelf: the $13.035 and $13.150 closes on 2026-08-11 and 2026-08-12 are the only floor the post-guidance advance has produced. A weekly close below $13.00 removes it and puts the whole 2026-07-22 gap back in play. Below $11.00 the entire advance that followed the guidance raise is ceded.\n\nOn the fundamental side, a Q3 2026 print (~2026-10-28, est.) that walks FY constant-currency growth back toward the old 3–5% band, or that narrows adjusted EBITDA below the $25M low end, breaks the reason the multiple moved. A Form 6-K announcing an equity offering, an ATM programme or an equity-linked refinancing would resolve the leverage question in the direction the equity cannot absorb. The passage of the 30-day window with no company news and no new high would confirm the maturing label rather than refute it; a flip to saturated would require mainstream coverage arriving into a price that has stopped responding.\n\n## Correlation Notes\n\n- Reports in USD with Europe & International as the largest growth contributor (+21.0% reported vs +18.0% cc in Q2 2026), so EUR/SEK–USD moves show up directly in reported revenue and in whether the $908.799M–$925.629M dollar guide is reachable.\n- Capital stack is multi-currency: SEK 1,700M Nordic bonds and a SEK 750M super senior RCF alongside the USD convertibles, so Nordic credit conditions and the dollar both feed the refinancing question.\n- Sits in the levered small-cap consumer complex rather than with staples majors: 31.91M shares outstanding and $462.73M of market value against $517.8M of borrowings means the equity behaves like the residual claim it is, with high beta to risk appetite and to headlines on plant-based peers.\n- Greater China (+11.6% reported, +5.6% cc in Q2 2026) carries tariff and geopolitical sensitivity that management flagged on the 2026-07-22 call.",
  "first_seen": "2026-08-04",
  "last_analyzed": "2026-08-22T09:50:52+00:00",
  "last_synthesized": "2026-08-22",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}